Skip to Content

B 793 (Rivastigmine Tartrate 1.5 mg)

Pill with imprint B 793 is Yellow, Capsule-shape and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Breckenridge Pharmaceutical, Inc..

Rivastigmine is used in the treatment of parkinson's disease; alzheimer's disease; lewy body dementia and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for B 793

Rivastigmine Tartrate

Imprint:
B 793
Strength:
1.5 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Cholinesterase inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Breckenridge Pharmaceutical, Inc.
National Drug Code (NDC):
51991-0793

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide